Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Clinical & Experimental OncologyISSN: 2324-9110
Chen-xi Lu Author
Subjects of specialization
Affiliation
Mucoepidermoid carcinoma, Cancer chemotherapy, Prostate biomarker
Department of Thoracic and Cardiovascular Surgery, Nantong First People
Biography
Chen-xi Lu was working in the Department of Thoracic and Cardiovascular Surgery, Nantong First People’s Hospital, Nantong 226001, Jiangsu Province, China. He has more than 40 publications. His current research area related to osteoarthropathy
Publications
Research Article Subscription
Prognostic Significance of KAI1/CD82 and its Relation Tod2-40 Labeled Lymphatic Vessel Invasion (LVI) and Lymphatic Vessel Density (LVD) in Esophageal Squamous Cell Carcinoma (ESCC)
Author(s): Hai-tao Huang, Fei Wan, Sheng-guang Ding, Chen-xi Lu and Chong-jun Zhong
Objectives: The KAI1/CD82 appears to inhibit multiple steps of cancer metastatic. D2-40 labeled LVI and LVD are also closely associated with cancer metastasis. We investigated the expression levels of KAI1/CD82, D2-40 labeled LVI and LVD and their correlation with clinicopathological factors in ESCC.
Methods: Immunohistochemistry and Western Blot were used to detect KAI1/CD82 expression levels in the peritumoral tissue and ESCC. LVI and LVD detected by D2-40 immunohistochemical staining. The relationships between the KAI1/CD82 expression levels, LVI and LVD were analyzed. The prognosis of ESCC was analyzed by Kaplan-M... view more»
Google Scholars / Researchers Sites
